We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-25.09%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.79B
AUM Growth
-$1.17B
Cap. Flow
-$394M
Cap. Flow %
-22.03%
Top 10 Hldgs %
23.27%
Holding
291
New
26
Increased
34
Reduced
190
Closed
30

Top Buys

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$13.4M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$12M
3
RDWR icon
Radware
RDWR
+$11.2M
4
KPTI icon
Karyopharm Therapeutics
KPTI
+$11M
5
PRGS icon
Progress Software
PRGS
+$10.7M

Top Sells

Rank Stock Value
1
PFGC icon
Performance Food Group
PFGC
+$19.8M
2
EBS icon
Emergent Biosolutions
EBS
+$19.3M
3
IMAX icon
IMAX
IMAX
+$16.9M
4
CY
Cypress Semiconductor
CY
+$16.8M
5
POOL icon
Pool Corp
POOL
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.39%
2 Technology 21.19%
3 Industrials 18.35%
4 Consumer Discretionary 10.8%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONTO icon
76
Onto Innovation
ONTO
$14.5B
$7.07M 0.4%
+238,206
New +$8.15M
INSM icon
77
Insmed
INSM
$29.4B
$7M 0.39%
436,905
-13,303
-3% -$315K
MRCY icon
78
Mercury Systems
MRCY
$6.52B
$6.8M 0.38%
95,331
-134,366
-58% -$10.2M
UTMD icon
79
Utah Medical Products
UTMD
$227M
$6.74M 0.38%
71,614
-9,252
-11% -$860K
NUVA
80
DELISTED
NuVasive, Inc.
NUVA
$6.54M 0.37%
129,124
-165,205
-56% -$11.1M
ENSG icon
81
The Ensign Group
ENSG
$10.7B
$6.44M 0.36%
171,344
-187,701
-52% -$8.23M
CHRS icon
82
Coherus Oncology
CHRS
$192M
$6.41M 0.36%
394,928
-302,625
-43% -$5.59M
MSM icon
83
MSC Industrial Direct
MSM
$6.87B
$6.39M 0.36%
116,295
-91,422
-44% -$6.02M
VRNT
84
DELISTED
Verint Systems
VRNT
$6.39M 0.36%
291,515
-224,501
-44% -$6.04M
BMRN icon
85
BioMarin Pharmaceuticals
BMRN
$13.3B
$6.08M 0.34%
71,938
-491
-0.7% -$42.3K
LNN icon
86
Lindsay Corp
LNN
$1.17B
$5.99M 0.33%
65,441
-70,089
-52% -$6.91M
ZWS icon
87
Zurn Elkay Water Solutions
ZWS
$8.47B
$5.99M 0.33%
548,400
-433,693
-44% -$6.33M
PCOM
88
DELISTED
Points.com Inc. Common Shares
PCOM
$5.91M 0.33%
718,204
-56,699
-7% -$829K
GLUU
89
DELISTED
Glu Mobile Inc.
GLUU
$5.89M 0.33%
+936,364
New +$6.03M
FIVE icon
90
Five Below
FIVE
$13B
$5.89M 0.33%
83,659
-53,993
-39% -$5.49M
CRTO icon
91
Criteo S.A. Ordinary Shares
CRTO
$902M
$5.79M 0.32%
727,877
-602,611
-45% -$7.68M
NBIX icon
92
Neurocrine Biosciences
NBIX
$16.8B
$5.71M 0.32%
66,033
-824
-1% -$80.6K
ACLS icon
93
Axcelis
ACLS
$4.1B
$5.7M 0.32%
311,442
-109,038
-26% -$2.53M
MTZ icon
94
MasTec
MTZ
$21.5B
$5.56M 0.31%
169,986
-72,898
-30% -$3.71M
ITGR icon
95
Integer Holdings
ITGR
$4.25B
$5.33M 0.3%
+84,841
New +$6.92M
VIAV icon
96
Viavi Solutions
VIAV
$9.18B
$5.25M 0.29%
+468,077
New +$6.37M
PRMW
97
DELISTED
Primo Water Corporation
PRMW
$5.17M 0.29%
570,838
-177,580
-24% -$2.42M
VRRM icon
98
Verra Mobility
VRRM
$720M
$5.08M 0.28%
712,085
-546,202
-43% -$7.27M
FC icon
99
Franklin Covey
FC
$242M
$5.07M 0.28%
326,401
-12,863
-4% -$368K
AZTA icon
100
Azenta
AZTA
$1.54B
$5.02M 0.28%
164,691
-220,927
-57% -$8.04M
2 3
4
5 6

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Rice Hall James & Associates held 291 positions worth $1.79B, down 39% from $2.96B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Rice Hall James & Associates withdrew a net $394M in Q1 2020, closing 30 positions and reducing 190 holdings. Its most notable exit was Performance Food Group, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Zogenix, Inc. worth $9.13M.

  • Rice Hall James & Associates's largest Q1 2020 buy was Zogenix, Inc.: 369,261 shares worth $9.13M.
  • Rice Hall James & Associates added most to Radware in Q1 2020, an estimated $11.2M increase.
  • Rice Hall James & Associates's biggest Q1 2020 reduction was Emergent Biosolutions, cutting an estimated $19.3M.
  • Rice Hall James & Associates fully exited Performance Food Group in Q1 2020, selling an estimated $19.8M.
  • Rice Hall James & Associates's ten largest holdings make up 23% of its $1.79B portfolio in Q1 2020.
  • Rice Hall James & Associates opened 26 new positions and closed 30 in Q1 2020.
  • Rice Hall James & Associates's portfolio value fell 39% quarter-over-quarter to $1.79B.

Based on Rice Hall James & Associates's 13F filing for Q1 2020, filed 15 May 2020.